在患有呼吸系统疾病的患者中使用计量剂量吸入器
Kalpana Paudel Aryal1, Nisha Rai2, Ratna Shila Banstola1
1Pokhara Nursing Campus Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.
Journal of Nepal Health Research Council
|August 8, 2025
概括
患有呼吸系统疾病的患者通常缺乏适当的技术来使用计量剂量吸入器 (MDI),尽管他们有足够的知识. 改善MDI技术对于有效的呼吸道疾病管理至关重要.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统护理 呼吸系统护理
- 患者教育 患者教育
背景情况:
- 计量剂量吸入器 (MDIs) 对于管理呼吸系统疾病至关重要.
- 错误的MDI使用显著降低了药物的疗效.
- 评估患者的知识和实践对于优化MDI治疗至关重要.
研究的目的:
- 评估患有呼吸道疾病的患者关于MDI使用的知识和实践技能.
- 发现对正确的MDI技术的理解和应用的差距.
主要方法:
- 一项涉及126名患有呼吸系统疾病的患者的横截面研究.
- 使用结构化问卷来评估MDI知识.
- 采用了基于世卫组织的检查清单来评估MDI吸入技术.
主要成果:
- 研究群体包括58.7%的女性,平均年龄为63.35岁.
- 52%的患者表现出对MDI的满意知识.
- 只有2.4%的患者表现出正确的MDI吸入技术,严重缺乏对吸入之间等待时间的认识.
结论:
- 尽管知识充足,但在基本的MDI使用步骤中存在重大缺陷.
- 医疗保健提供者必须实施有针对性的干预措施,以提高MDI知识和正确应用.
- 改善MDI的使用可以显著提高患有呼吸系统疾病的患者的生活质量.
相关概念视频
Inhaled Medications
394
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
394
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
583
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583
COPD: Management Using Bronchodilators and Corticosteroids
312
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
312
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
386
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
386


